- Home
- GALT vs BACQU Comparison
GALT vs BACQU Comparison
Compare GALT & BACQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- BACQU
- Stock Information
- Founded
- GALT 2000
- BACQU N/A
- Country
- GALT United States
- BACQU
- Employees
- GALT N/A
- BACQU N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- BACQU
- Sector
- GALT Health Care
- BACQU
- Exchange
- GALT Nasdaq
- BACQU NYSE
- Market Cap
- GALT 86.0M
- BACQU N/A
- IPO Year
- GALT N/A
- BACQU N/A
- Fundamental
- Price
- GALT $1.36
- BACQU $10.36
- Analyst Decision
- GALT Hold
- BACQU
- Analyst Count
- GALT 1
- BACQU 0
- Target Price
- GALT N/A
- BACQU N/A
- AVG Volume (30 Days)
- GALT 177.8K
- BACQU N/A
- Earning Date
- GALT 05-19-2025
- BACQU N/A
- Dividend Yield
- GALT N/A
- BACQU N/A
- EPS Growth
- GALT N/A
- BACQU N/A
- EPS
- GALT N/A
- BACQU N/A
- Revenue
- GALT N/A
- BACQU N/A
- Revenue This Year
- GALT N/A
- BACQU N/A
- Revenue Next Year
- GALT N/A
- BACQU N/A
- P/E Ratio
- GALT N/A
- BACQU N/A
- Revenue Growth
- GALT N/A
- BACQU N/A
- 52 Week Low
- GALT $0.73
- BACQU N/A
- 52 Week High
- GALT $3.41
- BACQU N/A
- Technical
- Relative Strength Index (RSI)
- GALT 49.34
- BACQU N/A
- Support Level
- GALT $1.26
- BACQU N/A
- Resistance Level
- GALT $1.63
- BACQU N/A
- Average True Range (ATR)
- GALT 0.12
- BACQU 0.00
- MACD
- GALT 0.02
- BACQU 0.00
- Stochastic Oscillator
- GALT 35.00
- BACQU 0.00
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About BACQU BLEICHROEDER ACQUISITION CORP. I UNIT 1 CL A & 1 RT
Bleichroeder Acquisition Corp I is a blank check company.